286 related articles for article (PubMed ID: 10947319)
1. Basis for nebulized antibiotics: droplet characterization and in vitro antimicrobial activity versus Staphylococcus aureus, Escherichia coli, and Pseudomonas aeruginosa.
Todisco T; Eslami A; Baglioni S; Sposini T; Tascini C; Sommer E; Knoch M
J Aerosol Med; 2000; 13(1):11-6. PubMed ID: 10947319
[TBL] [Abstract][Full Text] [Related]
2. In vitro susceptibility of methicillin-resistant Staphylococcus aureus to imipenem and other antimicrobial agents.
Ishag AJ; Durgham SM; Shibl AM
Chemioterapia; 1987 Aug; 6(4):261-3. PubMed ID: 3477333
[TBL] [Abstract][Full Text] [Related]
3. Suitability of a new antimicrobial aminosterol formulation for aerosol delivery in cystic fibrosis.
Alhanout K; Brunel JM; Dubus JC; Rolain JM; Andrieu V
J Antimicrob Chemother; 2011 Dec; 66(12):2797-800. PubMed ID: 21933787
[TBL] [Abstract][Full Text] [Related]
4. Nebulization and anti-Pseudomonas aeruginosa activity of colistin.
Diot P; Gagnadoux F; Martin C; Ellataoui H; Furet Y; Breteau M; Boissinot E; Lemarié E
Eur Respir J; 1997 Sep; 10(9):1995-8. PubMed ID: 9311491
[TBL] [Abstract][Full Text] [Related]
5. In vitro aerodynamic characterization of the dose emitted during nebulization of tobramycin high strength solution by novel and jet nebulizer delivery systems.
Mashat M; Clark BJ; Assi KH; Chrystyn H
Pulm Pharmacol Ther; 2016 Apr; 37():37-42. PubMed ID: 26747025
[TBL] [Abstract][Full Text] [Related]
6. ["In vitro" determination of bacterial sensitivity to tobramycin (author's transl)].
Talon D; Michel-Briand Y
Pathol Biol (Paris); 1976 Jan; 24(1):25-30. PubMed ID: 817253
[TBL] [Abstract][Full Text] [Related]
7. Different patterns of bacterial DNA synthesis during postantibiotic effect.
Gottfredsson M; Erlendsdóttir H; Gudmundsson A; Gudmundsson S
Antimicrob Agents Chemother; 1995 Jun; 39(6):1314-9. PubMed ID: 7574522
[TBL] [Abstract][Full Text] [Related]
8. Aerosolization of tobramycin (TOBI) with the PARI LC PLUS reusable nebulizer: which compressor to use? Comparison of the CR60 to the PortaNeb compressor.
Westerman EM; Boer AH; Touw DJ; Brun PP; Roldaan AC; Frijlink HW; Heijerman HG
J Aerosol Med Pulm Drug Deliv; 2008 Sep; 21(3):269-80. PubMed ID: 18759658
[TBL] [Abstract][Full Text] [Related]
9. In vitro antibacterial activity of imipenem against Pseudomonas and Staphylococcus species. Comparison with thirteen other antimicrobial agents.
Cristiano P; Abbate GF; Alagia I; Leonessa V; Giaquinto E; Savioli L
Drugs Exp Clin Res; 1985; 11(1):39-48. PubMed ID: 3869802
[TBL] [Abstract][Full Text] [Related]
10. Interpretive standards and quality control guidelines for imipenem susceptibility tests with 10-micrograms disks.
Barry AL; Thornsberry C; Gavan TL; Jones RN
J Clin Microbiol; 1984 Nov; 20(5):988-9. PubMed ID: 6439736
[TBL] [Abstract][Full Text] [Related]
11. Synergy of nebulized phage PEV20 and ciprofloxacin combination against Pseudomonas aeruginosa.
Lin Y; Chang RYK; Britton WJ; Morales S; Kutter E; Chan HK
Int J Pharm; 2018 Nov; 551(1-2):158-165. PubMed ID: 30223075
[TBL] [Abstract][Full Text] [Related]
12. Resistance of artificial biofilms of Pseudomonas aeruginosa to imipenem and tobramycin.
Coquet L; Junter GA; Jouenne T
J Antimicrob Chemother; 1998 Dec; 42(6):755-60. PubMed ID: 10052899
[TBL] [Abstract][Full Text] [Related]
13. Bactericidal effect of combinations of antibiotic and antineoplastic agents against Staphylococcus aureus and Escherichia coli.
Nyhlén A; Ljungberg B; Nilsson-Ehle I; Odenholt I
Chemotherapy; 2002 May; 48(2):71-7. PubMed ID: 12011538
[TBL] [Abstract][Full Text] [Related]
14. Effect of sulfur hexafluoride gas on antibacterial activity of antibiotics in vitro against agents causing endophthalmitis.
Yanyali A; Cetin S; Talu H; Vahaboglu H
Ophthalmologica; 2001; 215(6):439-43. PubMed ID: 11741112
[TBL] [Abstract][Full Text] [Related]
15. Comparison of in vivo intrinsic activity of cefepime and imipenem in a Pseudomonas aeruginosa rabbit endocarditis model: effect of combination with tobramycin simulating human serum pharmacokinetics.
Navas D; Caillon J; Gras-Le Guen C; Jacqueline C; Kergueris MF; Bugnon D; Potel G
J Antimicrob Chemother; 2004 Oct; 54(4):767-71. PubMed ID: 15317741
[TBL] [Abstract][Full Text] [Related]
16. [Comparison of antibacterial activities of Tobramycin inhalation solutions].
Pisarev VV
Antibiot Khimioter; 2013; 58(3-4):19-21. PubMed ID: 24640147
[TBL] [Abstract][Full Text] [Related]
17. Vanillin selectively modulates the action of antibiotics against resistant bacteria.
Bezerra CF; Camilo CJ; do Nascimento Silva MK; de Freitas TS; Ribeiro-Filho J; Coutinho HDM
Microb Pathog; 2017 Dec; 113():265-268. PubMed ID: 29107747
[TBL] [Abstract][Full Text] [Related]
18. Synergism and postantibiotic effect of tobramycin and Melaleuca alternifolia (tea tree) oil against Staphylococcus aureus and Escherichia coli.
D'Arrigo M; Ginestra G; Mandalari G; Furneri PM; Bisignano G
Phytomedicine; 2010 Apr; 17(5):317-22. PubMed ID: 19699074
[TBL] [Abstract][Full Text] [Related]
19. Cross-resistance between some aminoglycoside antibiotics.
Onaolapo JA
Afr J Med Med Sci; 1994 Sep; 23(3):215-9. PubMed ID: 7604744
[TBL] [Abstract][Full Text] [Related]
20. Combined effects of panipenem and aminoglycosides on methicillin-resistant Staphylococcus aureus and Pseudomonas aeruginosa in vitro.
Katou K; Nakamura A; Kato T; Tonegawa K; Kutsuna T; Niwa T; Morita H; Itoh M
Chemotherapy; 2005 Oct; 51(6):387-91. PubMed ID: 16227698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
